Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The Medical Journal of Australia|May 20, 2019
Hepatitis B management during immunosuppression for haematological and solid organ malignancies: an Australian consensus statementJoseph Doyle, Michelle Raggatt, Monica Slavin, et al.
American Journal of Hematology|May 3, 2024
Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed/refractory B-cell non-Hodgkin lymphomaSam Yuen, Tycel J Phillips, Rajat Bannerji, et al.
Internal Medicine Journal|August 5, 2024
Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceJoshua W D Tobin, Greg Hapgood, Anna Johnston, et al.
Blood Advances|January 4, 2018
Bortezomib-based antibody depletion for refractory autoimmune hematological diseasesSumita Ratnasingam, Patricia A Walker, Huy Tran, et al.
Practical Laboratory Medicine|August 29, 2022
Lot verification practices in Ontario clinical chemistry laboratories - Results of a patterns-of-practice surveyAngela C Rutledge, Anna Johnston, Ronald A Booth, et al.
Internal Medicine Journal|March 5, 2025
Haematological malignancies during pregnancy: a systematic review of necessary services in the Australian contextLuke Cassidy, Antonia Shand, Joanne M Said, et al.
British Journal of Haematology|June 26, 2019
Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma AllianceJoel C Wight, Mimi Yue, Colm Keane, et al.
Leukemia & Lymphoma|February 20, 2024
Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases RegistryDiva Baggio, Cameron Wellard, Eliza Chung, et al.
Internal Medicine Journal|July 8, 2024
Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern eraDiva Baggio, Eliza Chung, Cameron Wellard, et al.
British Journal of Haematology|October 31, 2023
Death from mantle cell lymphoma limits sequential therapy, particularly after first relapse: Patterns of care and outcomes in a series from Australia and the United KingdomAdrian Minson, Nada Hamad, Pietro Di Ciaccio, et al.
Pageof 7